Skip to content
HUMHumana

What Is HUM Fair Value?

Humana (HUM) fair value estimate using multiple valuation models, updated daily.

As of August 29, 2026, Humana (HUM) has a composite fair value estimate of $246.67 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $385.54, suggesting the stock is overvalued by 36.0%.

Data as of August 29, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$246.67

vs. current price of $385.54(-36.0%)

Undervalued$246.67Overvalued
$385.54

How Is HUM Fair Value Calculated?

Four independent models estimate what HUM is worth. Each uses different inputs and assumptions. The composite blends them by weight.

HUM Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$411.51

+6.7%

Fair Value

Inputs used

FCF: 1.9BGrowth: 5.0%Discount: 7%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$59.78

-84.5%

Overvalued

Inputs used

Dividend: $3.54/yrReq. Return: 9%Growth: 2.5%

HUM Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$181.52

-52.9%

Overvalued

Inputs used

EPS: $9.15Book Value: $160.00

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$91.53

-76.3%

Overvalued

Inputs used

EPS: $9.15Growth: 5.0%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$411.51Fair Value

Current price $385.54 is 6.7% below this estimate

CheapFair ValueExpensive
5.0%
0.0%30.0%
7.5%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$2.04B$1.90B
Year 2$2.14B$1.85B
Year 3$2.25B$1.81B
Year 4$2.36B$1.77B
Year 5$2.48B$1.73B
Year 6$2.60B$1.69B
Year 7$2.73B$1.65B
Year 8$2.87B$1.61B
Year 9$3.01B$1.58B
Year 10$3.16B$1.54B
Terminal Value$65.42B$31.88B

What Are HUM's Key Financial Metrics?

Earnings & Growth

Current Price

$385.54

EPS (TTM)

$10.37

Forward P/E

23.3

Profit Margin

0.9%

Cash & Balance Sheet

Free Cash Flow

1.9B

EBITDA

3.6B

Book Value

$160.00

Total Debt

14.7B

What Do Analysts Say About HUM?

Low

$280.00

Average

$418.61

High

$513.00

Upside

+8.6%

Current $385.54Avg Target $418.61Buy23 analysts

HUM Fair Value FAQ

What is the fair value of HUM?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), HUM's estimated fair value is $246.67. The stock is currently trading at $385.54, which makes it overvalued by our analysis.

How is HUM's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is HUM overvalued or undervalued?

Based on our analysis, HUM is overvalued. The current price of $385.54 is 36.0% above our estimated fair value of $246.67.

What do Wall Street analysts say about HUM?

23 analysts cover Humana with a consensus rating of "Buy." The average price target is $418.61, ranging from $280.00 to $513.00. This implies 8.6% upside from the current price.